Home › Overweight › Kansas › Topeka
Overweight clinical trials in Topeka, KS
7 studies for Overweight are looking for participants at sites in and around Topeka (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
RecruitingPhase 3
- Cotton-ONeil Diabetes and Endocrinology Center, Topeka
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
RecruitingPhase 3
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
RecruitingPhase 2
- Cotton O'Neil Diabetes & Endocrinology, Topeka
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
RecruitingPhase 3
- Cotton O'Neil Clinical Research Center, Topeka
Overweight trials in other cities
- San Antonio, TX34 studies
- Houston, TX33 studies
- Chicago, IL27 studies
- Orlando, FL25 studies
- Miami, FL23 studies
- Las Vegas, NV22 studies
- Atlanta, GA21 studies
- Dallas, TX20 studies
- Washington, DC19 studies
- Austin, TX19 studies
- New York City, NY19 studies
- Jacksonville, FL18 studies
Other studies in Topeka
- Steatotic Liver Disease7 studies
- Non-Small Cell Lung Cancer7 studies
- Prostate Cancer7 studies
- Breast Cancer6 studies
- Obesity6 studies
- Crohn's Disease6 studies
- Lung Cancer6 studies
- Cardiovascular Disease5 studies
- Melanoma4 studies
- Esophageal Cancer4 studies
- Bladder Cancer4 studies
- Type 2 Diabetes4 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.